192 related articles for article (PubMed ID: 26695140)
1. Characterization of a new highly sensitive immunometric assay for thyroglobulin with reduced interference from autoantibodies.
Broughton MN; Nome R; Sandven I; Paus E; Bjøro T
Tumour Biol; 2016 Jun; 37(6):7729-39. PubMed ID: 26695140
[TBL] [Abstract][Full Text] [Related]
2. Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma.
Ringel MD; Balducci-Silano PL; Anderson JS; Spencer CA; Silverman J; Sparling YH; Francis GL; Burman KD; Wartofsky L; Ladenson PW; Levine MA; Tuttle RM
J Clin Endocrinol Metab; 1999 Nov; 84(11):4037-42. PubMed ID: 10566646
[TBL] [Abstract][Full Text] [Related]
3. [Recovery test or immunoradiometric measurement of anti-thyroglobulin autoantibodies for interpretation of thyroglobulin determination in the follow-up of different thyroid carcinoma].
Zöphel K; Wunderlich G; Liepach U; Koch R; Bredow J; Franke WG
Nuklearmedizin; 2001 Oct; 40(5):155-63. PubMed ID: 11727628
[TBL] [Abstract][Full Text] [Related]
4. Discordance in thyroglobulin measurements by radioimmunoassay and immunometric assay: a useful means of identifying thyroglobulin assay interference.
Crane MS; Strachan MW; Toft AD; Beckett GJ
Ann Clin Biochem; 2013 Sep; 50(Pt 5):421-32. PubMed ID: 23847033
[TBL] [Abstract][Full Text] [Related]
5. Anti-thyroglobulin antibodies in differentiated thyroid carcinoma patients: Study of the clinical and biological parameters.
Rahmoun MN; Bendahmane I
Ann Endocrinol (Paris); 2014 Feb; 75(1):15-8. PubMed ID: 24560398
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the BRAHMS Kryptor(®) thyroglobulin minirecovery test in patients with differentiated thyroid carcinoma.
Giovanella L; Imperiali M; Verburg FA; Ceriani L
Clin Chem Lab Med; 2013 Feb; 51(2):449-53. PubMed ID: 23095203
[TBL] [Abstract][Full Text] [Related]
7. Serum thyroglobulin (Tg) monitoring of patients with differentiated thyroid cancer using sensitive (second-generation) immunometric assays can be disrupted by false-negative and false-positive serum thyroglobulin autoantibody misclassifications.
Spencer C; Petrovic I; Fatemi S; LoPresti J
J Clin Endocrinol Metab; 2014 Dec; 99(12):4589-99. PubMed ID: 25226290
[TBL] [Abstract][Full Text] [Related]
8. Highly sensitive serum thyroglobulin and circulating thyroglobulin mRNA evaluations in the management of patients with differentiated thyroid cancer in apparent remission.
Fugazzola L; Mihalich A; Persani L; Cerutti N; Reina M; Bonomi M; Ponti E; Mannavola D; Giammona E; Vannucchi G; di Blasio AM; Beck-Peccoz P
J Clin Endocrinol Metab; 2002 Jul; 87(7):3201-8. PubMed ID: 12107225
[TBL] [Abstract][Full Text] [Related]
9. Measuring thyroglobulin in patients with thyroglobulin autoantibodies: evaluation of the clinical impact of BRAHMS Kryptor® Tg-minirecovery test in a large series of patients with differentiated thyroid carcinoma.
Giovanella L; Verburg FA; Trimboli P; Imperiali M; Keller F; Ceriani L
Clin Chem Lab Med; 2019 Jul; 57(8):1185-1191. PubMed ID: 30835250
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of serum thyroglobulin and antithyroglobulin antibody in differentiated thyroid cancer after thyroid ablation].
Vincze B; Sinkovics I; Keresztes S; Gergye M; Boér A; Remenár E; Péter I; Szentirmay Z; Kremmer T; Kásler M
Magy Onkol; 2004; 48(1):27-34. PubMed ID: 15105893
[TBL] [Abstract][Full Text] [Related]
11. Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal?
Mariotti S; Barbesino G; Caturegli P; Marinó M; Manetti L; Pacini F; Centoni R; Pinchera A
J Clin Endocrinol Metab; 1995 Feb; 80(2):468-72. PubMed ID: 7852506
[TBL] [Abstract][Full Text] [Related]
12. Characterization of thyroglobulin epitopes in patients with autoimmune and non-autoimmune thyroid diseases using recombinant human monoclonal thyroglobulin autoantibodies.
Latrofa F; Ricci D; Grasso L; Vitti P; Masserini L; Basolo F; Ugolini C; Mascia G; Lucacchini A; Pinchera A
J Clin Endocrinol Metab; 2008 Feb; 93(2):591-6. PubMed ID: 18029466
[TBL] [Abstract][Full Text] [Related]
13. Thyroglobulin and thyroglobulin autoantibodies measurement using the automated KRYPTOR® platform in patients with differentiated thyroid carcinoma.
Giovanella L; Toffalori E; Ceriani L; Caputo M; Verburg FA
Horm Metab Res; 2011 Sep; 43(10):728-30. PubMed ID: 21932179
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of highly sensitive Tg assay in monitoring patients treated for differentiated thyroid cancer.
Iervasi A; Iervasi G; Ferdeghini M; Solimeo C; Bottoni A; Rossi L; Colato C; Zucchelli GC
Clin Endocrinol (Oxf); 2007 Sep; 67(3):434-41. PubMed ID: 17555505
[TBL] [Abstract][Full Text] [Related]
15. Serum thyroglobulin measurements with a high sensitivity enzyme-linked immunosorbent assay: is there a clinical benefit in patients with differentiated thyroid carcinoma?
Zöphel K; Wunderlich G; Smith BR
Thyroid; 2003 Sep; 13(9):861-5. PubMed ID: 14588100
[TBL] [Abstract][Full Text] [Related]
16. Thyroglobulin and thyroglobulin autoantibodies: interpret with care.
Loh TP; Chong HW; Kao SL
Endocrine; 2014 Jun; 46(2):360-1. PubMed ID: 24272592
[No Abstract] [Full Text] [Related]
17. Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy.
Giovanella L; Ceriani L; Ghelfo A; Maffioli M; Keller F
Clin Endocrinol (Oxf); 2007 Oct; 67(4):547-51. PubMed ID: 17561976
[TBL] [Abstract][Full Text] [Related]
18. Comparative plasma thyroglobulin measurements with three non-cross-reactive monoclonal antibodies in metastatic thyroid cancer patients.
Hüfner M; Pfahl H; Bethäuser H; Heilig B; Georgi P
Acta Endocrinol (Copenh); 1988 Aug; 118(4):528-32. PubMed ID: 3041727
[TBL] [Abstract][Full Text] [Related]
19. Highly sensitive immunoradiometric assay for serum thyroglobulin with minimal interference from autoantibodies.
Marquet PY; Daver A; Sapin R; Bridgi B; Muratet JP; Hartmann DJ; Paolucci F; Pau B
Clin Chem; 1996 Feb; 42(2):258-62. PubMed ID: 8595721
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of efficacy of various methods of thyroglobulin measurements in differentiated thyroid cancer].
Czernik E; Deja R; Gubała E; Kukulska A; Turska M; Dabrowska-Czuba E; Bartnikowa W; Jarzab B
Wiad Lek; 2001; 54 Suppl 1():339-48. PubMed ID: 12182046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]